The effect of haloperidol and intravenous acetaminophen in the treatment of primaryheadache in emergency

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190820044569N1

Enrollment

310

Registered

2022-07-19

Start date

2022-07-23

Completion date

Unknown

Last updated

2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headache.

Interventions

Intervention 1: Intervention group: Haloperidol 2.5 mg intravenously. Intervention 2: Control group: Intravenous acetaminophen,1 gram intravenously after dilution in 100 cc of normal saline.

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patients referred to the emergency ward with a history of primary headache

Exclusion criteria

Exclusion criteria: Patients whose headache started after 45 years of age Patients who were taking sedative and suddenly stopped taking sedative Patients with advanced liver failure Patients who do not have a definitive diagnosis of primary headache Patients taking nitrate drugs

Design outcomes

Primary

Measure	Time frame
Reducing the length of stay in the emergency room. Timepoint: 30 minutes after starting to take the drug. Method of measurement: Using the patient record.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Pouya Paknezhad

Tabriz University of Medical Sciences

pooya.paknejad@gmail.com+98 41 3335 2078

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026